Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
American Journal of Hematology
|
September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings
Paul J Hampel, Kari G Chaffee, Rebecca L King, et al.
American Journal of Hematology
|
July 10, 2018
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
Fortunato Morabito, Tait D Shanafelt, Massimo Gentile, et al.
Blood Cancer Journal
|
August 29, 2025
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee
Christine E Ryan, Inhye E Ahn, Aswin Sekar, et al.
American Journal of Hematology
|
April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index
Geffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Cancer Journal
|
February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Cecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Blood Cancer Journal
|
November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)
Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Leukemia
|
April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
Michelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Cancer Medicine
|
March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
Sameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
American Journal of Hematology
|
March 22, 2021
The prognostic significance of del6q23 in chronic lymphocytic leukemia
Hadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
American Journal of Hematology
|
September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings
Paul J Hampel, Kari G Chaffee, Rebecca L King, et al.
American Journal of Hematology
|
July 10, 2018
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
Fortunato Morabito, Tait D Shanafelt, Massimo Gentile, et al.
Blood Cancer Journal
|
August 29, 2025
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee
Christine E Ryan, Inhye E Ahn, Aswin Sekar, et al.
American Journal of Hematology
|
April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index
Geffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Cancer Journal
|
February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Cecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Blood Cancer Journal
|
November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)
Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Leukemia
|
April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
Michelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Cancer Medicine
|
March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
Sameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
American Journal of Hematology
|
March 22, 2021
The prognostic significance of del6q23 in chronic lymphocytic leukemia
Hadiyah Y Audil, Paul J Hampel, Daniel L Van Dyke, et al.
Page
of 19